A new Board member of directors, Brian King
Medical Device leader Brian King joins the Acrotec Group Board of Directors
In line with Acrotec’s intention to expand its Medtech division – with a focus on the United States – the Swiss group announces the appointment of Brian King, an American Medtech and Lifescience leader who has spent most of his career in high-level executive positions in some of the top global medical companies.
Brian King
The Swiss group’s ambition to enter the Medtech market, with a focus on the United States, has led shareholders to appoint Brian King to the Board of Directors.
He has more than 25 years of executive experience in both public and private companies, with a strong focus on serving America’s leading Medtech companies. He was most recently president and CEO of Viant Medical where he more than quadrupled the business in 2 years as well as chief transformation officer at DePuy Synthes, a Johnson & Johnson company.
Brian King previously spent over a decade at Covidien, working as Group President of the Emerging Markets division, President of Asia and Senior Vice President of Global Operations, responsible for manufacturing, quality, engineering and operational excellence for the entire company including overseeing nearly 70 production facilities worldwide.
He is an honors graduate of the United States Naval Academy and served as a jet pilot in the US Navy. He holds a master’s degree in civil engineering from Pennsylvania State University and a master’s degree in business administration from Harvard.
“Brian King will bring his exceptional expertise and a strong network in the global Medtech market,” explains François Billig, CEO of the Acrotec Group. “We want to acquire companies in the United States and strengthen the activity of our Medtech Division in Europe. Brian’s contribution will be highly valuable to us; he is a considerable asset, combined with the support of the Carlyle Group, our new investor, who also has deep experience and a proven track record in the Medtech market.”